Abstract: The invention relates to insecticidal and acaricidal agents which contain water-insoluble active compounds and water-soluble oxyalkylation products of compounds prepared by adding styrenes onto phenols or naphthols, and which form a colloidal solution when diluted with water, and to their use.

Abstract: A hair grower for animals comprising coix seeds or an extract thereof is disclosed. Also disclosed a method for increasing animal's hair in which animals are fed with a feed containing such hair grower.

Abstract: A method of combating plant-pathogenic bacteria, comprising applying to the bacteria or to a bacteria habitat a bactericidally effective amount of a cyclopropyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid derivative of the formula ##STR1## in which A represents straight-chain or branched alkylene with 1 to 6 carbon atoms or a >C.dbd.CH-- radical,R.sup.1 represents alkoxycarbonyl with 1 to 6 carbon atoms in the alkyl part, benzyloxycarbonyl, carboxyl, optionally substituted carbamoyl, cyano or dialkoxyphosphonyl or alkylsulphonyl with 1 to 4 carbon atoms in the alkyl part, andR.sup.2 represents hydrogen, alkoxycarbonyl with 1 to 6 carbon atoms in the alkyl part, benzyloxycarbonyl, optionally substituted carbamoyl, cyano, chlorine, acetyl, alkyl with 1 to 3 carbon atoms or phenyl, orR.sup.1 and R.sup.2, together with the carbon atom which they substitute, can also form a 2-oxo-tetrahydrofuryl ring,R.sup.3, R.sup.4, R.sup.5 and R.sup.

Abstract: A therapeutic composition containing allantoin and desoxyribonycleic acid is useful for the healing of wounds.

Abstract: An insect trap is provided which contains an attractant comprising a sufficient amount of unsaturated oxacyclododecanone selected from the group consisting of (Z-12-methyloxacyclododec-4-en-2-one (I),(Z,Z)-12-methyloxacyclododeca-4,7-dien-2-one (II), and the alkyl substituted products of the foregoing, the amount of the attractant being sufficient so as to effectively attract O. mercator beetles. The attractant may also comprise an aldehyde, preferably hexanal, octanal, or nonanal, and preferably in combination with I or II, or both.

Abstract: A neutralizer for cold waving comprising: (i) an oxidizing agent and (ii) at least one compound selected from the group consisting of the compounds having the general formula (I) to (XII), as follows. ##STR1## wherein --R.sub.1 and --R.sub.2 are independently --CH.sub.3, --CH.sub.2 OH, --CH.sub.2 Cl, --CH.sub.2 Br, --CH.sub.2 I, ##STR2## --CH.sub.2 COOR.sub.6, --CH.sub.2 CH.sub.2 COOR.sub.6, --CH.sub.2 COR.sub.6, --COR.sub.6, ##STR3## --R.sub.3, --R.sub.4, and --R.sub.5 are independently --H, --COR.sub.6, --COOR.sub.6, --Cl, --Br, --I, --NO.sub.2, --OCH.sub.3, --OH, and --COOH;--R.sub.6 is hydrogen atom, or an alkyl or alkenyl group having up to 3 carbon atoms;--R.sub.7 is --H, --OH, or --CH.sub.3 ; and--R.sub.8 is --H, --COCH(CH.sub.3).sub.2, --COCH.dbd.C(CH.sub.3).sub.2, --COCH.sub.3, ##STR4## This neutralizer generates no substantial mercaptan or other unpleasant odor when applied to the hair and forms an elastic and shiny permanent wave.

Abstract: A composition useful for the treatment of cancer comprises a colloidal or semi-colloidal suspension of DNA-repressor proteins derived from a finely divided mammal nerve tissue, particularly brain tissue.A method of treating cancer comprises administering to the patient a suitable daily dosage of the above composition, accompanied by the administration of suitable doses of immuno globulin (gamma-globulin), during a period of from 45 to 60 days.

Abstract: This invention relates to an immunopotentiator or an immunopotentiating method using spermidine or its pharmacologically acceptable salt as an active ingredient.

Abstract: A composition for overcoming snoring as well as a process for its use is disclosed. The composition according to the invention contains a surface active substance, a preserving agent and/or a substance acting bactericidally or fungicidally on the mucous membranes and optionally a substance for softening the mucous membranes in physiological common salt solution as well as optionally further additives which are compatible with the mucous membranes.

Abstract: A process for preparing a hair dye or bleach composition which comprises mixing a gelifiable liquid vehicle with an oxidizing solution having dissolved therein an incompatible cationic polymer. The resulting gel is applied to the hair and after an appropriate contact time, the hair is rinsed.

Abstract: An agent for the therapy of hypertension, which comprises as an effective component at least one compound selected from the group consisting of 9-chloro-5-oxo-7-(1H-tetrazol-5-yl)-5H-[1]benzopyrano[2,3-b]pyridine, a salt thereof and hydrates thereof.

Abstract: The dyeing compositions of the invention comprise at least one violet nitro dyestuff having a shade, on the Munsell scale, ranging from 7.5 P to 10 PB, and at least one yellow nitro dyestuff having a shade, on the Munsell scale, ranging from 10 Y to 2.5 Y, these violet and yellow dyestuffs being present in proportions such that their selectivity coefficients are substantially equal, the coefficients being from 3 to 8 when determined at a concentration of 0.1 to 0.6% by weight, the ratio by weight of the violet dyestuff to the yellow dyestuff being from 1:1 to 3:1.

Abstract: Hypertension and thrombotic conditions in mammals are treated by administration of sulphite, bisulphite or cyclic sulphite ester of a monohydric or polyhydric alcohol.

Abstract: The present invention provides a wound treating agent in powder form based on a swellable organic polymer, which comprises a cross-linked polymer of a hydrophilic acrylic or methacrylic acid derivative, which polymer is permeated by a gellable polysaccharide and/or protein or polypeptide, the agent being obtainable by polymerizing a hydrophilic acrylic or methacrylic acid derivative in the presence of a dissolved, gellable polysaccharide and/or protein or polypeptide and of a cross-linking agent.The present invention also provides a process for the production of this wound treating agent, wherein a hydrophilic acrylic or methacrylic acid derivative is polymerized in an aqueous solution of a gellable polysaccharide and/or protein or polypeptide in the presence of a cross-linking agent and of a conventional polymerization initiator, to give a transparent gel which is dried and pulverized.

Abstract: A dermatological coating material is prepared by combining a glyceryl stearate (glyceryl monostearate or glyceryl distearate) with a vitamin E component (.alpha.-tocopherol acetate, .alpha.-tocopherol and/or mixed tocopherols) to form a molten solution with the aid of heat, which solution, when cooled, forms a frozen solid or semi-solid solution at room temperature. The vitamin E component is hardened by this method. For some applications, the frozen solution is mixed or kneaded to eliminate or reduce crystal formation. In some embodiments, Jojoba oil is added as a third ingredient.Utility as cosmetic bases, Vaseline substitutes, protective coatings, bandages, dermatological putties, carriers for germicidal or therapeutic agents, hair groomers, lubricants, such as sexual lubricants, stick cosmetics, such as lipsticks, and lip glosses is shown.When .alpha.-tocopherol acetate is added to such solutions formed with .alpha.-tocopherol or mixed tocopherols, the unpleasant odors associated therewith are suppressed.

Abstract: A waving lotion for cold waving comprising:(i) a mercapto compound and (ii) an aqueous mixture obtained by heating (a) at least one compound selected from the group consisting of the compounds having the general formulae (I) to (XX), ##STR1## wherein R.sub.1 is hydrogen or an electron attractive group, R.sub.2 is hydrogen or an alkyl group having 1 to 4 carbon atoms, and R.sub.3 is hydrogen, a hydroxyl group, or a methyl group and (b) at least one cyclodextrin selected from the group consisting of .alpha., .beta., .gamma., and .delta.-cyclodextrins in an aqueous phase at a mole ratio of (a):(b)=1:9-1:1 at a temperature of 50.degree. C. to 100.degree. C.This waving lotion has no substantial mercaptan odor and generates no substantial or less of a mercaptan odor when applied to the hair.

Abstract: An aqueous waving lotion for cold waving comprising:(i) a mercapto compound, (ii) at least one compound selected from the group consisting of the compounds having the general formulae (I) to (XX), ##STR1## wherein R.sub.1 is hydrogen or an electron attractive group, R.sub.2 is hydrogen or an alkyl group having 1 to 4 carbon atoms, and R.sub.3 is hydrogen, a hydroxyl group, or a methyl group, and (iii) a cyclodextrin.This aqueous waving lotion has no substantial mercaptan odor and generates no substantial or less of a mercaptan odor when applied to the hair.

Abstract: A process is described which consists, in a first stage, in applying a composition based on a substance of vegetable or animal origin, a synthetic organic substance or a mineral substance, in suspension or in solution in a solvent and having a viscosity suitable for application to the hair, or as a powder, and making it possible to prevent or substantially to limit the passage of the dyestuffs and/or of the dyestuff precursors as far as the scalp, and, in a second stage, in dyeing the hair using one or more compositions, at least one of which contains either an oxidizable dyestuff or a direct dyestuff, the dyeing being followed, after an interval sufficient for coloring the hair, by rinsing and optionally by shampooing.

Abstract: A method for preventing or reducing dermal irritation caused by thioglycolate depilatories by applying capsaicin and/or its salt(s) to at least a portion of the depilated area.

Abstract: A chewable comestible product is disclosed which comprises a frappe component having a density of at least 1.0, and a syrup component including corn syrup, sugar, and water. An antacid is optionally included and may preferably be incorporated into the frappe component. A related method of preparing the comestible product is also disclosed, which includes the processing of the product of the invention by cold processing techniques.In the instance where the product includes an antacid, metallic user aftertaste is absent.